Fresenius SE & Co. KGaA

Share Issue/Capital Change • May 11, 2012

News Details

Ad-hoc | 11 May 2012 10:42

Fresenius SE & Co. KGaA: Fresenius successfully completes capital increase

Fresenius SE & Co. KGaA / Key word(s): Capital Increase/Capital Increase

11.05.2012 10:42

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA,
AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR
SALES WOULD BE PROHIBITED BY APPLICABLE LAW

Fresenius successfully completes capital increase

Fresenius successfully placed 13.8 million new ordinary shares today. Based
on the issue price of EUR73.50 per share, gross proceeds to the company
amount to EUR1,014.3 million.

The new shares have full dividend entitlement for the fiscal year 2012.
They are not entitled to the proposed dividend for the fiscal year 2011, to
be paid on May 14, 2012.

The capital increase is the first component of the financing for the
planned acquisition of RHÖN-KLINIKUM AG. On April 26, 2012, Fresenius had
announced its intention to make a voluntary public takeover offer of
EUR22.50 per share in cash. The Company also stated it intends to finance
the acquisition through a syndicated loan, a bond issue and equity
instruments.

Given the capital increase, the total number of outstanding ordinary shares
of Fresenius SE & Co. KGaA will increase from currently 163,366,002 to
177,166,002.

Deutsche Bank, J.P. Morgan and Société Générale acted as Joint Global
Coordinators and Joint Bookrunners for the offering. Unicredit, Commerzbank
and DZ Bank were Co-Bookrunners.

Important Notice:

This notice is not an offer for sale or a solicitation of an offer to
purchase any securities of Fresenius SE & Co. KGaA.

This notice is not an offer to purchase securities in the United States of
America. Securities may only be sold or offered for sale in the United
States of America following prior registration in accordance with the
regulations of the U.S. Securities Act of 1933 in its currently valid
version, or without prior registration only on the basis of an exemption.
No such registration is intended.

The information contained in this notice is intended neither for
publication nor for circulation in or within the United States of America,
and is not an offer to purchase securities in the United States of America.

Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management

Bad Homburg v.d.H., May 11, 2012

End of note

11.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart;
Terminbörse EUREX

End of Announcement DGAP News-Service

---